Cirrhosis and Liver Failure: Meeting Listing 5.05

Claimants with cirrhosis and chronic liver failure qualify for Social Security Disability Insurance (SSDI) under Blue Book Listing 5.05 by documenting serious clinical complications or achieving an SSA MELD score calculation of 22 or higher. The Social Security Administration (SSA) evaluates chronic end-stage liver disease under 20 CFR Part 404, Subpart P, Appendix 1 based on objective laboratory testing and documented hospital interventions.

Cirrhosis represents advanced, irreversible scarring of hepatic tissue caused by hepatitis infections, metabolic dysfunction-associated steatohepatitis, autoimmune conditions, or alcohol-associated liver disease. The Centers for Disease Control and Prevention reported in 2023 that chronic liver disease and cirrhosis caused over 52,000 deaths annually in the United States. When progressive liver decompensation impairs daily functioning, federal disability benefits provide vital income security.

How SSA Evaluates Liver Disease Under Listing 5.05

The Blue Book evaluates digestive disorders under Section 5.00, with Listing 5.05 covering chronic liver disease. SSA applies the five-step sequential evaluation process outlined in 20 CFR 404.1520 to determine disability. At Step 3, adjudicators compare your medical records against listing criteria.

Qualifying under Listing 5.05 establishes disability on clinical grounds alone. When you satisfy a listing, SSA approves your claim without evaluating your age, education, or past work experience.

A diagnosis of cirrhosis or chronic hepatitis alone never guarantees approval. SSA requires objective proof of end-stage liver dysfunction, confirmed through specialized blood panels, diagnostic imaging, or documented acute medical interventions.

Qualifying via the MELD Calculation Under Listing 5.05G

The most common objective method for proving disability from liver failure is Listing 5.05G, which relies on the Model for End-Stage Liver Disease (MELD). Under Section 5.00D4, SSA uses an arithmetic MELD calculation to measure mortality risk and organ failure severity.

To meet Listing 5.05G, you must have an SSA MELD score calculation of 22 or higher, documented on at least two evaluations at least 30 days apart within a consecutive 12-month period. This timing requirement proves that severe liver failure is chronic rather than a brief, transient fluctuation.

Under Section 5.00D4b, the MELD formula incorporates three primary serum laboratory values:

• Serum total bilirubin, measuring the liver's ability to excrete bile pigments.
• Serum creatinine, assessing secondary renal impairment caused by hepatic dysfunction.
• International normalized ratio (INR), measuring prothrombin time and the liver's capacity to synthesize blood clotting proteins.

Adjudicators calculate the score using values from hospital or laboratory reports. If your laboratory values produce a MELD score of 22 or higher on two occasions separated by at least 30 days, your impairment meets Listing 5.05G at Step 3.

Qualifying Through Specific Clinical Complications

Claimants whose MELD scores remain below 22 can qualify under alternative subsections of Listing 5.05 by documenting severe clinical complications:

Listing 5.05A covers hemorrhaging from esophageal, gastric, or ectopic varices, or from portal hypertensive gastropathy. You must document bleeding that requires hospitalization for transfusion of at least two units of blood. This bleeding must occur on at least three separate occasions within a consecutive 12-month period, with at least 30 days between episodes.

Listing 5.05B covers ascites or hydrothorax not attributable to other causes. The fluid accumulation must persist despite continuing prescribed treatment, documented on at least two evaluations at least 60 days apart within a consecutive 12-month period. Objective proof requires paracentesis, thoracentesis, or diagnostic imaging like abdominal ultrasound or CT scans.

Listing 5.05C covers spontaneous bacterial peritonitis (SBP). Documentation must show peritoneal fluid with an absolute neutrophil count of at least 250 cells per cubic millimeter.

Listing 5.05D covers hepatorenal syndrome. The medical record must document progressive renal failure associated with liver disease, showing serum creatinine of 2.0 mg/dL or higher, oliguria with 24-hour urine output under 500 mL, or 24-hour urine sodium excretion under 10 mEq/L.

Listing 5.05E covers hepatopulmonary syndrome, documented by arterial blood oxygenation levels while breathing room air or intrapulmonary arteriovenous shunting.

Listing 5.05F covers hepatic encephalopathy, characterized by cognitive dysfunction, asterixis (flapping tremor), and sleep-wake cycle reversal, documented on two evaluations at least 60 days apart within a consecutive 12-month period.

The Drug Addiction and Alcoholism Rule Under 20 CFR 404.1535

Many individuals with cirrhosis have a history of alcohol-associated liver disease. A history of alcohol consumption does not automatically bar a claimant from receiving SSDI benefits.

Under 20 CFR 404.1535 and Social Security Ruling 13-2p, SSA conducts a Drug Addiction and Alcoholism (DAA) materiality analysis only after determining that a claimant is disabled. Adjudicators must answer a specific legal question: Would the claimant still be disabled if they stopped using alcohol?

If substance use is the sole cause of a temporary condition that would resolve with sobriety, benefits are denied. However, cirrhosis causes permanent structural damage to the liver architecture, including irreversible fibrous bands and regenerative nodules. When portal hypertension, esophageal varices, or chronic decompensation remain severe and disabling even with total alcohol abstinence, DAA is not material, and benefits are approved.

Qualifying via Residual Functional Capacity

If your liver failure does not satisfy Listing 5.05 criteria, you can still qualify for SSDI through a Residual Functional Capacity (RFC) assessment. Under 20 CFR 404.1545, an RFC evaluates the maximum physical and mental work you can sustain on a full-time basis.

Cirrhosis imposes severe exertional and non-exertional limitations:

• Profound physical fatigue and muscle wasting due to protein-calorie malnutrition and metabolic failure, often restricting claimants to sedentary work.
• Inability to lift, carry, or bend due to massive abdominal ascites or painful umbilical and incisional hernias.
• Bleeding risks that eliminate jobs involving sharp tools, heavy equipment, or physical hazards.
• Cognitive slowing from subclinical hepatic encephalopathy, affecting processing speed, concentration, and memory.
• Frequent medical absenteeism for paracentesis procedures, banding of varices, and specialist appointments.

Vocational expert testimony confirms that missing two or more workdays per month or being off-task more than 15 percent of an eight-hour shift eliminates competitive employment.

At Step 4 under 20 CFR 404.1520(f), SSA evaluates whether your RFC allows past relevant work. Following the 2024 update to 20 CFR 404.1560(a)(1) and Social Security Ruling 24-2p, SSA reviews only work performed in the prior five years. If past work is precluded, SSA evaluates your age, education, and skills at Step 5 using the Medical-Vocational Guidelines in 20 CFR Part 404, Subpart P, Appendix 2.

Non-Medical Eligibility Criteria in 2026

To receive monthly SSDI payments, claimants must also satisfy non-medical statutory requirements.

Under 20 CFR 404.130, you must have accumulated sufficient work credits through Social Security covered employment. In 2026, a worker earns one credit for every $1,810 of earnings, up to four credits per year. Claimants age 31 and older must generally satisfy the 20/40 rule, having earned 20 credits during the 40 quarters immediately before disability onset.

Under 20 CFR 404.1574, claimants must not engage in substantial gainful activity. In 2026, the monthly SGA earnings threshold is $1,690 for non-blind individuals. Earning above this limit triggers an administrative denial at Step 1 regardless of medical severity. Under 20 CFR 404.1509, your condition must also meet the continuous 12-month duration requirement. Application filing procedures and administrative appeals are distinct stages covered in separate resources and are outside the scope of this article.

Frequently Asked Questions

What MELD score qualifies for SSDI under Listing 5.05G? Listing 5.05G requires an SSA MELD calculation score of 22 or higher, documented on at least two evaluations at least 30 days apart within a consecutive 12-month period. SSA calculates this score using your laboratory values for serum total bilirubin, serum creatinine, and international normalized ratio.

How does SSA evaluate ascites or variceal bleeding from cirrhosis? Under Listing 5.05A, variceal bleeding must require hospital transfusion of at least two units of blood on three occasions at least 30 days apart within 12 months. Under Listing 5.05B, ascites must persist despite treatment on two evaluations at least 60 days apart within 12 months, confirmed by paracentesis or imaging.

Does a history of alcohol use prevent you from getting SSDI for cirrhosis? No. Under 20 CFR 404.1535, SSA evaluates whether substance use is a contributing factor material to disability. If your cirrhosis and liver failure have caused irreversible structural damage that remains disabling even if you stop drinking, your claim can be approved.

This article is general information about Social Security Disability Insurance eligibility, not legal advice. Program rules, earnings limits, and evaluation standards change over time, and every situation is different. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.